140 related articles for article (PubMed ID: 9722073)
1. Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation.
Sleight BJ; Prasad VS; DeLaat C; Steele P; Ballard E; Arceci RJ; Sidman CL
Bone Marrow Transplant; 1998 Aug; 22(4):375-80. PubMed ID: 9722073
[TBL] [Abstract][Full Text] [Related]
2. Correction of Fas (CD95) deficiency by haploidentical bone marrow transplantation.
Benkerrou M; Le Deist F; de Villartay JP; Caillat-Zucman S; Rieux-Laucat F; Jabado N; Cavazzana-Calvo M; Fischer A
Eur J Immunol; 1997 Aug; 27(8):2043-7. PubMed ID: 9295043
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune lymphoproliferative syndrome (ALPS) in a patient with a new germline Fas gene mutation.
Del-Rey MJ; Manzanares J; Bosque A; Aguiló JI; Gómez-Rial J; Roldan E; Serrano A; Anel A; Paz-Artal E; Allende LM
Immunobiology; 2007; 212(2):73-83. PubMed ID: 17336828
[TBL] [Abstract][Full Text] [Related]
4. ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Puck JM; Sneller MC
Semin Immunol; 1997 Feb; 9(1):77-84. PubMed ID: 9106310
[TBL] [Abstract][Full Text] [Related]
5. Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.
Shenoy S; Arnold S; Chatila T
J Pediatr; 2000 May; 136(5):682-7. PubMed ID: 10802504
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune lymphoproliferative syndrome (ALPS) caused by Fas (CD95) mutation mimicking sarcoidosis.
Müllauer L; Emhofer J; Wohlfart S; Pichlhöfer B; Stary S; Ebetsberger G; Mannhalter C; Chott A
Am J Surg Pathol; 2008 Feb; 32(2):329-34. PubMed ID: 18223337
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
Worth A; Thrasher AJ; Gaspar HB
Br J Haematol; 2006 Apr; 133(2):124-40. PubMed ID: 16611303
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune lymphoproliferative syndrome in a patient with a new minimal deletion in the death domain of the FAS gene.
Gualco G; van den Berg A; Koopmans S; Bacchi LM; Carneiro SS; Ruiz E; Vecchi AP; Chan JK
Hum Pathol; 2008 Jan; 39(1):137-41. PubMed ID: 18070632
[TBL] [Abstract][Full Text] [Related]
9. Pathological findings in human autoimmune lymphoproliferative syndrome.
Lim MS; Straus SE; Dale JK; Fleisher TA; Stetler-Stevenson M; Strober W; Sneller MC; Puck JM; Lenardo MJ; Elenitoba-Johnson KS; Lin AY; Raffeld M; Jaffe ES
Am J Pathol; 1998 Nov; 153(5):1541-50. PubMed ID: 9811346
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune lymphoproliferative syndrome associated with severe humoral immunodeficiency and monoclonal gammopathy.
Nanan R; Ströbel P; Haas JP; Marx A; Kreth HW
Ann Hematol; 2002 Jun; 81(6):332-5. PubMed ID: 12107564
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Holzelova E; Vonarbourg C; Stolzenberg MC; Arkwright PD; Selz F; Prieur AM; Blanche S; Bartunkova J; Vilmer E; Fischer A; Le Deist F; Rieux-Laucat F
N Engl J Med; 2004 Sep; 351(14):1409-18. PubMed ID: 15459302
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune lymphoproliferative syndrome: a cause of chronic splenomegaly, lymphadenopathy, and cytopenias in children-report on diagnosis and management of five patients.
Alvarado CS; Straus SE; Li S; Dale JK; Mann K; Le A; Lauer SJ
Pediatr Blood Cancer; 2004 Aug; 43(2):164-9. PubMed ID: 15236285
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune lymphoproliferative syndrome (ALPS): a case with congenital onset.
Kahwash SB; Fung B; Savelli S; Bleesing JJ; Qualman SJ
Pediatr Dev Pathol; 2007; 10(4):315-9. PubMed ID: 17638424
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome.
Tighe PJ; Stevens SE; Dempsey S; Le Deist F; Rieux-Laucat F; Edgar JD
Genes Immun; 2002 Oct; 3 Suppl 1():S66-70. PubMed ID: 12215906
[TBL] [Abstract][Full Text] [Related]
15. Identical phenotype in patients with somatic and germline CD95 mutations requires a new diagnostic approach to autoimmune lymphoproliferative syndrome.
Rössler J; Enders A; Lahr G; Heitger A; Winkler K; Fuchs H; Kopp M; Niemeyer C; Ehl S
J Pediatr; 2005 Nov; 147(5):691-4. PubMed ID: 16291365
[TBL] [Abstract][Full Text] [Related]
16. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
[TBL] [Abstract][Full Text] [Related]
17. Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome.
Lim WK; Ursea R; Rao K; Buggage RR; Suhler EB; Dugan F; Chan CC; Straus SE; Nussenblatt RB
Am J Ophthalmol; 2005 Mar; 139(3):562-3. PubMed ID: 15767081
[TBL] [Abstract][Full Text] [Related]
18. HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).
Vacek MM; Schäffer AA; Davis J; Fischer RE; Dale JK; Adams S; Straus SE; Puck JM
Clin Immunol; 2006 Jan; 118(1):59-65. PubMed ID: 16257267
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD95 on mature leukocytes of MRL/lpr mice after transplantation of genetically modified bone marrow stem cells.
Federzoni E; Gordon G; Müller S; Schmid I; Simon HU; Yousefi S
Immunol Lett; 2008 Apr; 117(1):45-9. PubMed ID: 18222547
[TBL] [Abstract][Full Text] [Related]
20. [Successful donor lymphocyte infusion for Epstein-Barr virus-associated lymphoproliferative disorder after allogeneic bone marrow transplantation from an HLA 1-locus-mismatched sibling donor in a patient with acute lymphocytic leukemia].
Yago K; Itoh M; Shimada H
Rinsho Ketsueki; 2001 Nov; 42(11):1105-10. PubMed ID: 11808079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
